WELL surpassed $1 billion annualized revenue run-rate with record revenue of $251.7 million in Q3-2024, marking a 27% (1) increase compared to Q3-2023, mainly driven by organic growth of 23%. WELL achieved record Adjusted EBITDA (2) of $32.7 million in Q3-2024, an increase of 16% as compared to Q3-2023. WELL achieved a record total of 1.5 million total patient visits in Q3-2024 an increase of 41% compared to Q3-2023 and... Read More